Recently, MLPH has been shown to correlates with the progression of various tumors, and has become a prognostic indicator and treatment target for a variety of tumors, such as Spitz tumor16, melanoma 17, small cell lung cancer18, bladder cancer 19, prostate cancer20, breast cancer21, and rectal cancer22. This evidence concerns the gene MLPH and melanoma.